Caplin Point Q2 results: net profit rises 13.8% to Rs 182.35 crore
Caplin Point Laboratories told the NSE its consolidated net profit rose 13.8% to Rs 182.35 crore in the September 2026 quarter, with revenue from operations up 17.9% to Rs 629.84 crore.
Key points
- Caplin Point Laboratories said in an NSE filing that consolidated net profit for Q2 FY27 was Rs 182.35 crore, up 13.8% from a year earlier.
- Revenue from operations was Rs 629.84 crore, up 17.9% year on year and 3.2% from the previous quarter, according to the filing.
- The results are unaudited and were reviewed by the company's statutory auditors; the full statements are in the company's NSE filing.
Caplin Point Laboratories reported consolidated net profit of Rs 182.35 crore for the quarter ended 30 September 2026 (Q2 FY27), up 13.8% from Rs 160.23 crore a year earlier. Revenue from operations rose 17.9% to Rs 629.84 crore, according to the company's filing with the National Stock Exchange on 12 November 2026.
What Happened
The company said in its filing that its Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026 at a meeting held on 12 November 2026. The results were reviewed, not audited, by the company's statutory auditors, who said in their limited review report that nothing had come to their attention suggesting the statements contained a material misstatement.
The figures below are consolidated, in Rs crore, as the company's investor presentation in the filing gives them.
Revenue from operations was Rs 629.84 crore in Q2 FY27, against Rs 534.04 crore in Q2 FY26, a rise of 17.9%. Compared with the previous quarter, Q1 FY27, when it was Rs 610.36 crore, it rose 3.2%.
Profit after tax for the period was Rs 182.35 crore, against Rs 160.23 crore a year earlier, a rise of 13.8%. Against Rs 179.09 crore in the previous quarter, it rose 1.8%.
For the six months ended 30 September 2026 (H1 FY27), revenue from operations was Rs 1,240.20 crore, up 18.8% from Rs 1,044.26 crore a year earlier. Profit after tax for the half year was Rs 361.42 crore, up 16.2% from Rs 310.99 crore.
The presentation also shows that profit before tax rose 15.8% to Rs 232.83 crore in the quarter, and that tax expense was Rs 50.48 crore against Rs 40.77 crore a year earlier.
The filing also records that shareholders approved a final dividend of Rs 4 per equity share for FY 2025-26 on 25 September 2026, and that it was paid on 7 October 2026. The total dividend for FY 2025-26, including the interim dividend, was Rs 8 per equity share.
What It Means
For shareholders and others who follow the company, the filing shows profit and revenue both higher than a year earlier, with profit growing more slowly than revenue in the quarter. Profit after tax rose 13.8%, while revenue from operations rose 17.9%. The tax expense for the quarter rose faster than pre-tax profit.
These figures are unaudited and come from the company's own statements. Readers can see the full consolidated and standalone statements, including notes, in the company's filing with the National Stock Exchange. Oquilia does not offer investment advice.
Oquilia Data: Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT)
| Close, 11 Nov 2026 | Rs 2,520.30 (+0.71% on the day) |
|---|---|
| Return 1M / 3M / 6M / YTD / 1Y | +2.42% / −4.16% / +35.99% / +37.11% / +29.39% |
| Against Nifty 50, 1M / 3M / YTD | −9.72 / −7.36 / +40.46 points |
| 52-week closing high / low | Rs 2,867.40 (24 Sep 2026) / Rs 1,504.80 (30 Mar 2026) |
| Turnover, 20-session average | Rs 19.42 cr; 44.3% delivered; latest volume 1.0x |
Closes adjusted for splits and bonuses; returns exclude dividends. Facts from NSE's files, not investment advice.
Full record: Caplin Point Laboratories share price on Oquilia
Source: Company filing on NSE
Sources & Citations
- Company filing on NSE — National Stock Exchange of India